Papers using
SHIP2
antibodies
Papers on
SHIP2
Endophilin marks and controls a clathrin-independent endocytic pathway.McMahon et al., Cambridge, United Kingdom. In Nature, Feb 2015
This pathway is prominent at the leading edges of cells where phosphatidylinositol-3,4-bisphosphate-produced by the dephosphorylation of phosphatidylinositol-3,4,5-triphosphate by SHIP1 and SHIP2-recruits lamellipodin, which in turn engages endophilin.
Breast cancer stem cells, EMT and therapeutic targets.Bhattacharya et al., India. In Biochem Biophys Res Commun, 2014
This review also lists the miRNA interactions identified in BCSCs and discusses on some newly identified targets in the BCSC regulatory pathways like SHIP2, nicastrin, Pin 1, IGF-1R, pro-inflammatory cytokines and syndecan which can be targeted for therapeutic achievements.
Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).Takenawa et al., Kōbe, Japan. In J Biol Chem, 2012
Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).
Inositol polyphosphate phosphatases in human disease.Mitchell et al., Australia. In Curr Top Microbiol Immunol, 2011
Additionally, polymorphisms in the 5-phosphatase SHIP2 confer diabetes susceptibility in specific populations, whereas reduced protein expression of SHIP1 is reported in several human leukaemias.
The lipid phosphatase SHIP2 controls insulin sensitivity.Schurmans et al., Belgium. In Nature, 2001
In vitro studies have shown that SHIP2, in response to stimulation by numerous growth factors and insulin, is closely linked to signalling events mediated by both phosphoinositide-3-OH kinase and Ras/mitogen-activated protein kinase.